SCOTT CLAYCOMB, MD
Ophthalmology Physician in MONTICELLO, Arkansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
SCOTT CLAYCOMB, MD reported a CMS MIPS final score of 80.0943/100 — below the 83.1 national average — and filed 5,299 Medicare Part D claims in 2023.
- 80.0943/100
- MIPS score · -3 vs avg
- 5K
- Part D claims, 2023
- 67%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
SCOTT CLAYCOMB, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
80 33rd percentile higher than 33% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
SCOTT CLAYCOMB, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about SCOTT CLAYCOMB, MD?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Arkansas
How Ophthalmology Physician compares to other specialties among Arkansas providers
Ophthalmology Physician share within Arkansas
Ophthalmology Physician is one of the more visible NUCC categories in Arkansas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
SCOTT CLAYCOMB, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 80.0943/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) — 80.0943/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Ophthalmology Physician US NPIs
80.0943/100 MIPS final score — 3.0 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 73.0805.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
SCOTT CLAYCOMB, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 301 HIGHWAY 425 S, MONTICELLO, AR, 71655, with a listed phone of (870) 367-8534. NPI 1083610505 was issued on 06/21/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CLAYCOMB most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 5,299 prescription claims written by this provider, covering 989 Medicare beneficiaries and totaling roughly $434K in drug spend, split 33% brand-name and 67% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 80.0943/100 for the 2023 performance year (Quality 73.0805), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1083610505 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/21/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm SCOTT CLAYCOMB, MD's current license status, disciplinary history, and board certifications with the Arkansas State Medical Board in Arkansas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SCOTT CLAYCOMB, MD. Source: openpaymentsdata.cms.gov.
Total received
$222
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
33% brand-name claims vs 67% generic, on 5,299 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 7,033
- Total Day Supply
- 180,104
- Brand vs Generic
- 33% brand / 67% generic
- Brand Drug Cost
- $337K
- Generic Drug Cost
- $97K
- Antibiotic Claims
- 116
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.51
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 100, 65-74: 405, 75-84: 348, 85+: 136
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What SCOTT CLAYCOMB, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
1,907 claims
- Prednisolone Acetate 653
Prednisolone Acetate
653 claims
- Dorzolamide-Timolol 579
Dorzolamide-Timolol
579 claims
- Ofloxacin 335
Ofloxacin
335 claims
- Timolol Maleate 280
Timolol Maleate
280 claims
- Erythromycin 173
Erythromycin
173 claims
- Ketorolac Trometha… 163
Ketorolac Tromethamine
163 claims
- Lumigan 151
Lumigan
151 claims
| Drug | Claims |
|---|---|
| Latanoprost | 1,907 |
| Prednisolone Acetate | 653 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 579 |
| Ofloxacin | 335 |
| Timolol Maleate | 280 |
| Erythromycin Erythromycin Base | 173 |
| Ketorolac Tromethamine | 163 |
| Lumigan Bimatoprost | 151 |
| Alphagan P Brimonidine Tartrate | 106 |
| Moxifloxacin Moxifloxacin Hcl | 97 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How SCOTT CLAYCOMB, MD fits within the Ophthalmology Physician landscape nationally.
SCOTT CLAYCOMB, MD's 5,299 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in Arkansas
Other clinicians with the same primary specialty enrolled in Arkansas, drawn from the same CMS NPPES roster as CLAYCOMB.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Arkansas
Frequently Asked Questions
What is SCOTT CLAYCOMB, MD's specialty? ▼
How much does SCOTT CLAYCOMB, MD prescribe under Medicare Part D? ▼
What is SCOTT CLAYCOMB, MD's Medicare quality score? ▼
Where is SCOTT CLAYCOMB, MD located? ▼
What is SCOTT CLAYCOMB, MD's NPI number? ▼
Does SCOTT CLAYCOMB, MD prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does SCOTT CLAYCOMB, MD prescribe most often? ▼
Does SCOTT CLAYCOMB, MD accept Medicare? ▼
How can I verify SCOTT CLAYCOMB, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology